Evidence map›Paper›PMID 26753686›Full record

ArticleJournal of evidence-based complementary & alternative medicine2017

Cancer Phytotherapy: Recent Views on the Role of Antioxidant and Angiogenesis Activities.

Mahmood Bahmani, Hedayatollah Shirzad, Najmeh Shahinfard, Laaleh Sheivandi, Mahmoud Rafieian-Kopaei

Abstract read
In one paragraph

Article in Journal of evidence-based complementary & alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmood Bahmani1 Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Hedayatollah Shirzad2 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Najmeh Shahinfard3 Virtual School, Department of E-Learning in Medical Education, Tehran University of Medical Sciences, Tehran, Iran.
Laaleh Sheivandi2 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mahmoud Rafieian-Kopaei2 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, increases in resistance of tumors to the current therapeutic agents have become a problematic issue. Therefore, efforts to discover new anticancer compounds with high sensitivity of cancer cells are extending. Animal and laboratory researches have shown that exogenous antioxidants are able to help prevent the free radical damage associated with the development of cancer. However, researches in human beings have not demonstrated convincingly that taking antioxidants can reduce the risk of developing cancer. Angiogenesis is also a natural condition that controls the formation of new blood vessels from the available vessels. Today, it is believed that most of the cancers have angiogenesis potential and their growth, metastasis, and invasion depend on angiogenesis. Several compounds with plant origin and with anti-angiogenic properties have been identified. The aim of this study is to review recently published articles about anticancer drugs obtained from plants with antioxidant and anti-angiogenesis properties.

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic AgentsAntioxidantsHumansNeoplasmsPhytotherapyAngiogenesis InhibitorsAntineoplastic AgentsAntioxidantsangiogenesisantioxidantscancermedicinal plantstumor

Identifiers

PMID26753686
PMCPMC5871176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.